Jacob Adashek: Patients with KRAS G12C Vascular Malformations with profound responses to Sotorasib

Jacob Adashek posted on X:

“Razelle Kurzrock with hattrick ‘Benign drivers’ – cancer drugs repurposed for NON-cancer conditions!

Patients with KRAS G12C Vascular Malformations with PROFOUND responses to Sotorasib.”

Additional information.
Source: Jacob Adashek/X

Jacob Adashek is a medical oncology fellow at the Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins Hospital. With a focus on precision medicine, personalized therapies, and first-in-human clinical trials and being interested in biomarker-driven early-phase clinical trials, he has contributed to over 70 peer-reviewed articles in medical journals like Nature Clinical Reviews Oncology and JAMA Oncology. He has done clinical research at the City of Hope, specializing in genitourinary oncology, and remains an active member of the American Society of Clinical Oncology and the American Association for Cancer Research.